METHSCOPOLAMINE BROMIDE Reviews (METHSCOPOLAMINE BROMIDE)

Average Rating: 3.0 (1 Ratings)

Filter Results

Compare METHSCOPOLAMINE BROMIDE with similar:

 Type: Rx Drug

  

METHSCOPOLAMINE BROMIDE  (METHSCOPOLAMINE BROMIDE):  Methscopolamine is used with other drugs to treat a certain type of stomach/intestinal ulcer (peptic ulcer). This medication may help relieve stomach/abdominal pain. However, it has not been shown to be effective in healing these ulcers, preventing them from returning, or preventing other problems caused by ulcers. Methscopolamine works by decreasing the amount of acid in the stomach. It also slows the natural movements of the gut and relaxes the muscles in the stomach/intestines. Methscopolamine belongs to a class of drugs known as anticholinergics.    (Sources: U.S. Centers for Medicare Services, FDA)

  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR METHSCOPOLAMINECOMMENTSSEXAGEDURATION/
DOSAGE
DATE ADDED
 
 3  colitis Very bad dry mouth, lost my voice, dry eyes, dizziness, drugged up feeling. Not sure if its working yet but i'm taking in in combination with asacol. Flare ups have been reduced dramatically. Stopped for a couple days and had a bad flare up. Bad diet probably had something to do with it. F 29 7 days
9/10/2008
  

METHSCOPOLAMINE BROMIDE  (METHSCOPOLAMINE BROMIDE):  Methscopolamine is used with other drugs to treat a certain type of stomach/intestinal ulcer (peptic ulcer). This medication may help relieve stomach/abdominal pain. However, it has not been shown to be effective in healing these ulcers, preventing them from returning, or preventing other problems caused by ulcers. Methscopolamine works by decreasing the amount of acid in the stomach. It also slows the natural movements of the gut and relaxes the muscles in the stomach/intestines. Methscopolamine belongs to a class of drugs known as anticholinergics.    (Sources: U.S. Centers for Medicare Services, FDA)

     

BACK TO TOP